ストックスクリーナーアプリを入手
2.76
1.43%
-0.04
アフターアワーズ：
2.73
-0.03
-1.09%
前日終値:
$2.80
開ける：
$2.8
24時間の取引高:
78,765
Relative Volume:
0.44
時価総額：
$108.71M
収益：
$63.15M
当期純損益:
$-40.30M
株価収益率:
-1.6527
EPS:
-1.67
ネットキャッシュフロー:
$-44.47M
1週間 パフォーマンス:
+3.76%
1か月 パフォーマンス:
-2.82%
6か月 パフォーマンス:
-34.29%
1年 パフォーマンス:
-59.88%
1日の値動き範囲:
$2.73
$2.87
1週間の範囲:
$2.56
$2.87
52週間の値動き範囲:
$2.30
$7.52
Tela Bio Inc Stock (TELA) Company Profile
名前
Tela Bio Inc
セクター
電話
484-320-2930
住所
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
2.76 | 108.71M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-05-31 | 開始されました | Lake Street | Buy |
| 2019-12-03 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-12-03 | 開始されました | Jefferies | Buy |
| 2019-12-03 | 開始されました | Piper Jaffray | Overweight |
Tela Bio Inc (TELA) 最新ニュース
Annovis Bio Raises $21 Million in Public Offering to Advance Alzheimer’s Research - MyChesCo
Annovis Bio Announces Public Offering of Common Stock and Warrants - MyChesCo
TELA Bio Inc to Host Earnings Call - ACCESS Newswire
TELA Bio Grants Inducement Stock Units to New Employees - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
TELA Bio Awards Equity Incentives to Seven New Strategic Hires - StockTitan
Jane Street Group LLC Sells 76,505 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by Geode Capital Management LLC - Defense World
Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28% - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by State Street Corp - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3% – Here’s Why - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3%Should You Sell? - MarketBeat
TELA Bio Announces Inducement Grants for New Employees - MSN
TELA Bio's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
TELA Bio's SWOT analysis: stock poised for growth amid challenges - Investing.com
TELA Bio Awards Strategic Inducement Grants to Secure Key New Talent - StockTitan
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable - Yahoo Finance
Earnings call: TELA Bio reports strong Q3 growth, eyes future gains - Investing.com Nigeria
TELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in November - MarketBeat
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
GSA Capital Partners LLP Purchases 89,712 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio to Present at Canaccord Genuity’s Growth Conference - MSN
TELA Bio Reports Strong Revenue Growth in Q3 2024 - MSN
TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - The Manila Times
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference - GlobeNewswire
TELA Bio's SWOT analysis: innovative medical device stock faces growth hurdles - Investing.com India
TELA Bio, Inc. (NASDAQ:TELA) Sees Large Decline in Short Interest - MarketBeat
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript - Insider Monkey
TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely - Simply Wall St
TELA Bio stock target cut, keeps overweight rating on Q3 results - Investing.com Nigeria
TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy
Tela Bio price target lowered to $5 from $8 at Piper Sandler - TipRanks
Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings) - Benzinga
Piper Sandler Has Lowered Expectations for TELA Bio (NASDAQ:TELA) Stock Price - MarketBeat
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates - MSN
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance Australia
TELA Bio, Inc. Reports Record Revenue Growth - TipRanks
TELA Bio Inc Q3 2024 Earnings: Revenue Hits $19M, EPS at -$0.42, - GuruFocus.com
Tela Bio earnings missed by $0.02, revenue topped estimates - Investing.com UK
Tela Bio Inc (TELA) 財務データ
収益
当期純利益
現金流量
EPS
5.14%
2.09%
大文字化:
|
ボリューム (24 時間):